The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Revenue

The Arab Drug Company had revenue of 306.02M EGP in the quarter ending September 30, 2025, with 31.16% growth. This brings the company's revenue in the last twelve months to 1.19B, up 43.89% year-over-year. In the fiscal year ending June 30, 2025, The Arab Drug Company had annual revenue of 1.12B with 42.35% growth.

• Revenue (ttm): 1.19B
• Revenue Growth: +43.89%
• P/S Ratio: 1.95
• Revenue / Employee: 1.04M
• Employees: 1,152
• Market Cap: 2.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.12B	332.65M	42.35%
Jun 30, 2024	785.52M	151.79M	23.95%
Jun 30, 2023	633.73M	128.69M	25.48%
Jun 30, 2022	505.04M	-32.01M	-5.96%
Jun 30, 2021	537.05M	16.25M	3.12%